Efficacy and Safety of Sublingual Fentanyl Tablets in Treatment of Breakthrough Pain in Cancer Patients.
NCT00262678 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2009-06-04
Summary
The purpose of this study is to determine the effectiveness and safety of sublingual fentanyl tablets in relieving breakthrough pain in cancer patients.
Conditions
Interventions
- DRUG
-
EN3267
Sponsors & Collaborators
-
Kyowa Kirin Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-12-31
- Primary Completion
- 2008-12-31
- Completion
- 2009-01-31
Countries
- United States
Study Locations
More Related Trials
-
Sublingual Fentanyl for the Management of Breakthrough Pain
NCT02514252 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of Fentanyl ETHYPHARM for Breakthrough Pain in Opioid-treated Patients With Cancer
NCT01842893 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer
NCT00269737 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer Pain
NCT00236327 ·Status: TERMINATED ·Phase: PHASE4
-
An Efficacy and Safety Study of Fentanyl (JNS020QD) in Participants With Cancer Pain
NCT00641667 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients
NCT00842829 ·Status: TERMINATED ·Phase: PHASE4
-
Clinical Use and Safety of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer
NCT00269763 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase III Clinical Study of KW-2246 for Breakthrough Pain in Cancer Patients
NCT00684632 ·Status: COMPLETED ·Phase: PHASE3
-
Analgesic Treatment for Cancer Pain in South East Asia
NCT02664987 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Effectiveness of Fentanyl-TTS Compared to Weak Opioids in Patients With Moderate to Severe Chronic Cancer Pain Previously Treated With NSAIDS (Non-steroidal Anti-inflammatory Drugs).
NCT00576017 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Oral Morphine Versus Nasal Ketamine Spray With Chitosan in Cancer Pain Outpatients
NCT02591017 ·Status: TERMINATED ·Phase: PHASE3
-
Oral Piroxicam Versus Buccal Fentanyl in Breakthrough Pain
NCT02382653 ·Status: COMPLETED ·Phase: NA
-
Correlation Between the Analgesic Effect of Fentanyl Transdermal Patches and Nutritional Status in Cancer Pain Patients
NCT06369961 ·Status: COMPLETED
-
Effectiveness and Tolerance of Fentanyl Citrate in Painful Pain Induced During Diagnostic or Therapeutic Examinations in Cancer Patients
NCT03809455 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Dose-Finding Study of Fentanyl (JNS020 QD) 1-Day Transdermal Patch in Participants With Cancer Pain
NCT00644787 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Opioid Titration With 12.5 ug/h Fentanyl Transdermal Patch vs Orally Morphine for Opioid-naïve Patients With Moderate Cancer Pain
NCT04533243 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of BEMA™ Fentanyl in the Treatment of Breakthrough Pain in Cancer Subjects
NCT00293033 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial With Intranasal Fentanyl in Cancer Patients With Breakthrough Pain
NCT01429051 ·Status: COMPLETED ·Phase: PHASE3
-
A Dose Titration Study of Fentanyl Buccal Soluble Film for Breakthrough Cancer Pain in Taiwan
NCT03669263 ·Status: COMPLETED ·Phase: NA
-
Nasal Fentanyl for Chronic Cancer Pain
NCT01906073 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Comparative Study of KW-2246
NCT01326689 ·Status: COMPLETED ·Phase: PHASE3
-
Real World Study of Oxycodone Sustained-release Tablets for Patients With Moderate to Severe Cancer Pain
NCT05962294 ·Status: UNKNOWN
-
Long-term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain
NCT00538863 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study of KW-2246 in Patients With Cancer Pain
NCT00355628 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Injectable Fentanyl in Sublingual Route Versus Oral Morphine Syrup for Breakthrough Pain
NCT05037539 ·Status: COMPLETED ·Phase: PHASE1/PHASE2